Xtant Medical Holdings, Inc. (XTNT) Earnings History
Annual and quarterly earnings data from 2008 to 2024
Loading earnings history...
XTNT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
XTNT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 58.2% | -10.3% | -14.0% |
| 2023 | 60.8% | -11.1% | 0.7% |
| 2022 | 55.4% | -11.7% | -14.6% |
| 2021 | 58.8% | -7.0% | -8.8% |
| 2020 | 64.5% | -1.4% | -13.2% |
Download Data
Export XTNT earnings history in CSV or JSON format
Free sign-in required to download data
Xtant Medical Holdings, Inc. (XTNT) Earnings Overview
As of May 8, 2026, Xtant Medical Holdings, Inc. (XTNT) reported trailing twelve-month net income of $2M. The company earned $0.01 per diluted share over the past four quarters, with a net profit margin of -14.0%.
Looking at the long-term picture, XTNT's historical earnings data spans multiple years. The company achieved its highest annual net income of $660,000 in fiscal 2023.
Xtant Medical Holdings, Inc. maintains positive profitability with a gross margin of 58.2%, operating margin of -10.3%, and net margin of -14.0%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including ATEC (-$125M net income, -18.8% margin), NVCR (-$173M net income, -20.8% margin), OSPN ($70M net income, 30.0% margin), XTNT has outperformed on profitability metrics. Compare XTNT vs ATEC →
XTNT Earnings vs Peers
Earnings metrics vs comparable public companies
XTNT Historical Earnings Data (2008–2024)
17 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$16M | -2592.3% | -$12M | $-0.12 | -14.0% | -10.3% |
| 2023 | $660,000 | +107.8% | -$10M | $0.01 | 0.7% | -11.1% |
| 2022 | -$8M | -75.0% | -$7M | $-0.09 | -14.6% | -11.7% |
| 2021 | -$5M | +31.0% | -$4M | $-0.06 | -8.8% | -7.0% |
| 2020 | -$7M | +14.6% | $-751,000 | $-0.25 | -13.2% | -1.4% |
| 2019 | -$8M | +88.3% | -$2M | $-0.62 | -12.7% | -3.6% |
| 2018 | -$70M | -33.7% | -$60M | $-5.93 | -97.1% | -83.2% |
| 2017 | -$52M | -168.9% | -$38M | $-34.51 | -63.4% | -45.8% |
| 2016 | -$19M | -796.5% | -$8M | $-18.32 | -21.7% | -8.4% |
| 2015 | -$2M | +79.3% | -$12M | $-2.62 | -3.7% | -20.4% |
See XTNT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs XTNT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare XTNT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonXTNT — Frequently Asked Questions
Quick answers to the most common questions about buying XTNT stock.
Is XTNT growing earnings?
XTNT TTM EPS: $0.01. Net income: $2M. Earnings growth: N/A.
What are XTNT's profit margins?
Xtant Medical Holdings, Inc. net margin is -14.0%, with operating margin at -10.3%. Below-average margins reflect competitive or cost pressures.
How consistent are XTNT's earnings?
XTNT earnings data spans 2008-2024. The current earnings trend is N/A YoY. Historical data enables comparison across business cycles.